02 Feb
2023
16:19 E.S.T.

Cellectis Announces Launch of Follow-On Offering

Read more

20 Jan
2023
16:30 E.S.T.

Cellectis Amends $20 Million Convertible Note Under Collaboration Agreement with its Partner Cytovia Therapeutics

Read more

17 Jan
2023
07:10 E.S.T.

Calyxt and Cibus Announce the Signing of a Definitive Merger Agreement

Read more

04 Jan
2023
17:00 E.S.T.

Cellectis Establishes an At-The-Market (ATM) Program on Nasdaq

Read more